Reinjury of arterial lesions induces intimal smooth muscle cell replication that is not controlled by fibroblast growth factor 2

Circulation Research

Volumn 80, Issue 3, 1997, Pages 408-417

  Koyama, Hiroyuki ^b   Reidy, Michael A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

angioplasty; fibroblast growth factor 2; smooth muscle cell replication

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HEPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CELL DIVISION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; FOGARTY CATHETER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031052751     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.res.0000435857.23307.bd     Document Type: Article

References (36)

1. Block PC, Myler RK, Stertzer S, Fallon JT. Morphology after transluminal angioplasty in human beings. N Engl J Med. 1981;305:382-385.
2. Essed CE, van den Brand M, Becker AE. Transluminal coronary angioplasty and early restenosis: flbrocellular occlusion after wall laceration. Br Heart J. 1983;49:393-396.
3. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF, Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1985;6:369-375.
4. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP, Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation. 1994;89:2809-2815.
5. Post MJ, Borst C, Kuntz RE, The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. Circulation. 1994;89:2816-2821.
6. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol. 1995;25:516-520.
7. MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized double-blind placebo-controlled trial. Circulation. 1992;86:100-110.
8. Faxon DP, Spiro TE, Minor S, Coté G, Douglas J, Gottlieb R, Califf R, Dorosti K, Topol E, Gordon JB, Ohmen M, the ERA Investigators. Low molecular weight heparin in prevention of restenosis after angioplasty: results of enoxaparin restenosis (ERA) trial. Circulation. 1994;90:908-914.
9. Emanuelsson H, Beatt KJ, Bagger J, Balcon R, Heikkilä J, Piessens J, Schaeffer M, Suryapranata H, Foegh M. Long-term effects of angiopeptin treatment in coronary angioplasty: reduction of clinical events but not angiographic restenosis. Circulation. 1995;91:1689-1696.
10. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
11. Clowes AW, Clowes MM, Reidy MA, Kinetics of cellular proliferation after arterial injury, III: endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest. 1986;54:295-303.
12. Guyton JR, Dao DT, Lindsay KL, Endothelial denudation and myointimal thickening in the rat carotid artery induced by the passage of bubbles. Exp Mol Pathol. 1984;40:340-348.
13. Groves HM, Kiniough-Rathbone RL, Richardson M, Moore S, Mustard JF, Platelet interaction with damaged rabbit aorta. Lab Invest. 1979;40:194-200.
14. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 1993;13:1218-1226.
15. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
16. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest. 1991;88:904-910.
17. Olson NE, Chao S, Lindner V, Reidy MA, Intimal smooth muscle cell proliferation after balloon catheter injury: the role of basic fibroblast growth factor. Am J Pathol. 1992;140:1017-1023.
18. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986;103:2787-2796.
19. Dijkstra CD, Döpp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology, 1985;54:589-599.
20. Murry CE, Giachelli CM, Schwartz, SM, Vracko R, Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol. 1994;145:1450-1462.
21. Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries: interaction of heparin with basic fibroblast growth factor. J Clin Invest. 1992;90:2044-2049.
22. Reilly TM, Taylor DS, Herblin WF, Thoolen MJ, Chiu AT, Watson DW, Timmermans PBMWM. Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. Biochem Biophysic Res Commun. 1989;164:736-743.
23. Mohammadi M, Dionne CA, Li W, Li N, Spivak T, Honegger AM, Jaye M, Schlessinger J, Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature. 1992;358:681-684.
24. Bowen-Pope DF, Ross R, Platelet-derived growth factor, II: specific binding to cultured cells. J Biol Chem. 1982;257:5161-5171.
25. Lindner V, Lappi DA, Baird A, Majsck RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation, Circ Res. 1991;68:106-113.
26. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor .Proc Natl Acad Sci USA. 1991;88:3739-3743.
27. Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA, 1986;83:7311-7315.
28. Majesky MW, Giachelli CM, Reidy MA, Schwartz SM, Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 1992;71:759-768.
29. Schwartz SM, Foy L, Bowen-Pope DF, Ross R. Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am J Pathol. 1990;136:1417-1428.
30. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res. 1993;73:223-231.
31. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR, Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res. 1990;67:651-659.
32. Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis: a nonhuman primate model of restenosis. Arterioscler Thromb Vasc Biol. 1996;16:34-43.
33. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW, Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 1994;75:650-658.
34. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
35. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries, N Engl J Med. 1987;316:1371-1375.
36. Jamal A, Bendeck M, Langille BL. Structural changes and recovery of function after arterial injury. Arterioscler Thromb. 1992;12:307-317.